Form 4: Labcorp Executive Mark S. Schroeder Reports Stock Transactions
SEC Form 4 Filing
EVP, Pres Diagnostics & COO Mark S. Schroeder reports the vesting of restricted stock units and subsequent stock withholding for tax obligations.
Summary
- On March 27, 2024, Mark S. Schroeder, EVP, Pres Diagnostics & COO of Laboratory Corporation of America Holdings (Labcorp), reported transactions involving Labcorp common stock.
- Schroeder acquired 11,556 shares of common stock through the vesting of Restricted Stock Units (RSUs).
- Simultaneously, 5,079 shares were withheld to satisfy tax obligations at a price of $216.57 per share.
- Following these transactions, Schroeder directly owns 11,513.1426 shares of Labcorp common stock and 4,065 RSUs.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of stock transactions.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency into the trading activities of company executives. It is a standard practice for publicly traded companies and their officers.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- The disclosure provides transparency to shareholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 03/27/2024 | Date of stock transactions (RSU vesting and stock withholding). |
| 03/29/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.